Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is among the fundamentally strong penny stocks to invest in. Analysts at H.C. Wainwright have reiterated their Buy rating on Processa Pharmaceuticals, Inc.

To date, six other meta-analyses of prokinetic agents for treatment of FD have been reported ( Table 2). [43,44,45,46,47,48] In terms of the agents investigated and the scope of the literature ...

Functional dyspepsia is often treated with prokinetic agents; however, the efficacy of these agents in this patient population has recently been questioned.

5. Prokinetic Drugs Another class of prescription drugs, prokinetic agents, are prescribed to people with severe acid reflux. They are most often prescribed when other treatments do not work.

As 2025 progresses, VALORANT is evolving with plenty of new updates. Agents like Chamber and Viper who once ruled the meta with an iron fist have descended to l ...

Clinical trials of erythromycin as a prokinetic agent in preterm neonates have reported conflicting results. Aim: To systematically review the efficacy and safety of erythromycin as a prokinetic agent ...

A strong LES helps prevent GERD from developing. Prokinetic agents may not be helpful in lowering symptoms of GERD, however, and because there are concerns over potential adverse effects, prokinetic ...

Background: Prokinetic agents are currently considered the first-line therapy to improve gastric emptying when feeding intolerance occurred in critically ill adults. In this study, we developed a ...